NCT05239455View on ClinicalTrials.gov

An In Vivo 24-Hour Recovery Study of Whole Blood by the Reveos System

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

November 11, 2021

Primary Completion Date

April 30, 2022

Study Completion Date

April 30, 2022

Conditions
Device Validation of In-vivo Performance
Interventions
DEVICE

Reveos® Automated Blood Processing System

This is a non-interventional study, observing the in vivo performance of LR-RBC units derived from WB processed with the Reveos System.

Trial Locations (2)

45267

Hoxworth Blood Center, University of Cincinnati, Cincinnati

98102

Bloodworks Northwest Research Institute, Seattle

All Listed Sponsors
lead

Terumo BCT

INDUSTRY

NCT05239455 - An In Vivo 24-Hour Recovery Study of Whole Blood by the Reveos System | Biotech Hunter | Biotech Hunter